TAK logo
Takeda Pharmaceutical Company Limited(TAK)
Last print unknown agoAbout this dataData status
$19.61▼-0.06 (-0.31%)Stale · unknown oldEarnings · Oct 29

TAK Financing Cash Flow

-¥462.27BTTM · JPY

Period ending:

TAK FY Cash from FinancingJPY
TAK FY Cash from Financing2000-03-31: -¥27.91B2001-03-31: -¥41.91B2002-03-31: -¥52.66B2003-03-31: -¥58.99B2004-03-31: -¥59.34B2005-03-31: -¥73.91B2006-03-31: -¥89.29B2007-03-31: -¥315.94B2008-03-31: -¥262.08B2009-03-31: -¥425.84B2010-03-31: -¥148.05B2011-03-31: -¥146.54B2012-03-31: ¥393.79B2013-03-31: -¥152.20B2014-03-31: ¥96.50B2015-03-31: -¥301.00B2016-03-31: -¥124.84B2017-03-31: ¥289.90B2018-03-31: -¥326.23B2019-03-31: ¥2.95T2020-03-31: -¥1.01T2021-03-31: -¥1.09T2022-03-31: -¥1.07T2023-03-31: -¥709.15B2024-03-31: -¥354.42B2025-03-31: -¥751.43B2026-03-31: -¥496.82B¥2.95T-¥1.09T
2000-03-312026-03-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in JPY. Dates are period ends; a fiscal year may differ from a calendar year.

TAK financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 27 observations from Mar 31, 2000 to Mar 31, 2026.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Financing Cash Flow — Annual fiscal periods (JPY)
Period endingFinancing Cash Flow (JPY)
-496,820,000,000
-751,425,000,000
-354,416,000,000
-709,148,000,000
-1,070,265,000,000
-1,088,354,000,000
-1,005,213,000,000
2,946,237,000,000
-326,226,000,000
289,896,000,000
-124,839,000,000
-300,998,000,000
96,502,000,000
-152,202,000,000
393,789,000,000
-146,544,000,000
-148,046,000,000
-425,840,000,000
-262,082,000,000
-315,942,000,000
-89,290,000,000
-73,912,000,000
-59,344,000,000
-58,990,000,000
-52,658,000,000
-41,910,000,000
-27,907,000,000

Compare financing cash flow

All TAK financial metrics · TAK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.